Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : $0.50 & UNDER (Short term trades) -- Ignore unavailable to you. Want to Upgrade?

To: Ed Pakstas who wrote (421)	1/5/1998 3:55:00 PM
From: marcos	Read Replies (1) \| Respond to of 783

NVN is just coming off year-end dumping, there's no new news that I'm aware of. Keeping current on biotechs is hard, especially when you don't know what the words mean -g-. Their protein technology gets respect, though, and they have a shot at a home run while Chondrex should bring positive cash flow before long. Well-managed, or so they say. Here's the thread; exchange2000.com George Fan is in touch with the company more than I am. Ed, in the Tracker, you have NVN on the TSE, also in the chart you have NUN. Now that the year-end is over, I've stopped trading NVN, and likely won't take any profit under .34, might sell a third of position at .38 or .39, but will keep a fair bit in any case as it doesn't owe me anything and will do well in the medium term. Imho. Thanks for all your work on this thread and others, Ed, it's much appreciated. .............. cheers ................ marcos